-
3341
CD22 modulation alleviates amyloid β-induced neuroinflammation
Published 2025-02-01Get full text
Article -
3342
Bacterial extracellular vesicles in the initiation, progression and treatment of atherosclerosis
Published 2025-12-01Get full text
Article -
3343
Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma
Published 2019-01-01“…The patient received induction therapy with bortezomib, thalidomide, and dexamethasone (VTD), followed by high-dose melphalan chemotherapy and autologous stem cell transplantation, and then VTD consolidation, and finally maintenance with lenalidomide. …”
Get full text
Article -
3344
Minimally Invasive Bilateral Lung Resections and CABG through 5 Ports
Published 2018-01-01“…An 81-year-old woman was diagnosed with T1aN0M0 left upper lobe small-cell lung cancer and underwent single-port left video-assisted thoracoscopic surgery (VATS) upper lobectomy in 2016. …”
Get full text
Article -
3345
The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia
Published 2022-01-01“…Distribution of gender ratio, age, SAPS II, time of ventilation before tracheostomy, and preexisting hematooncological diseases was comparable between the two groups. After allogeneic stem cell transplantation (alloSCT), patients were more likely to undergo PDT than OST (p=0.033). …”
Get full text
Article -
3346
Amelioration of dextran sodium sulphate-induced colitis in mice by treatment with Lactobacillus rhamnosus and Lactobacillus reuteri: intraspecific and interspecific patterns
Published 2024-09-01“…Nevertheless, Re strains were more effective than Rh strains in inhibiting production of inflammatory factors; promoting production of intestinal mucus, antimicrobial peptides, and tight junction proteins; and supporting the stem cell compartment. This accounts for the anti-colitis outcomes of Re strains being superior to those of Rh strains. …”
Get full text
Article -
3347
Macrofocal multiple myeloma in the era of novel agents in China
Published 2025-01-01“…MFMM patients demonstrated better overall responses compared to the control cohort ( p = 0.027) in those not receiving upfront autologous stem cell transplantation (ASCT). During a median follow-up of 42.8 months for the entire cohort, the MFMM cohort exhibited significantly superior progression-free survival (PFS) and overall survival (OS) compared to the control cohort. …”
Get full text
Article -
3348
Impact of daily diet on military training injuries among high-altitude officers and soldiers
Published 2025-01-01Get full text
Article -
3349
Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
Published 2018-01-01“…SOS is a rare complication of stem cell transplantation and has significant morbidity and mortality. …”
Get full text
Article -
3350
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient
Published 2025-01-01“…Here we present a case study of a patient undergoing allogeneic hematopoietic stem cell transplantation with a 521-day follow-up of a SARS-CoV-2 infection with the BF.7.21 variant. …”
Get full text
Article -
3351
The different faces of GATA2 deficiency: implications for therapy and surveillance
Published 2024-06-01“…Due to the elevated risk of progression, nearly all individuals with GATA2-related MDS eventually undergo a hematopoietic stem cell transplantation (HSCT) at some point in their lives. …”
Get full text
Article -
3352
How to Deal with Pulpitis: An Overview of New Approaches
Published 2025-01-01“…This review explores emerging techniques, including autogenic and allogenic pulp transplantation, platelet-rich fibrin, human amniotic membrane scaffolds, specialized pro-resolving mediators, nanofibrous and bioceramic scaffolds, injectable hydrogels, dentin matrix proteins, and cell-homing strategies. These methods utilize stem cells, growth factors, and biomaterials to regenerate vascularized, functional pulp tissue. …”
Get full text
Article -
3353
Increased local DNA methylation disorder in AMLs with DNMT3A-destabilizing variants and its clinical implication
Published 2025-01-01“…This epigenetic heterogeneity was associated with the transcriptional variability of developmental and membrane-associated factors shaping stem cell niche, and also was a predictor of the response of AML cells to hypomethylating agents, implying that the survival of AML cells depends on stochastic DNA methylations at bivalent domains. …”
Get full text
Article -
3354
-
3355
Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies
Published 2021-01-01“…To describe retinal findings in a patient with mucopolysaccharidosis type I (MPS I) that underwent an early treatment with hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT). …”
Get full text
Article -
3356
Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis
Published 2020-09-01“…There are also at least 25 registered trials of azithromycin (n=53), convalescent plasma (n=38), lopinavir/ritonavir (n=30), stem cell treatments (n=29) and tocilizumab (n=25). 142 trials were registered in the first 3 months of 2020, and 488 trials were registered between 1 April and 1 May 2020.Conclusions These findings demonstrate a robust research response to the COVID-19 pandemic, though many of the currently planned and ongoing trials focus on a small number of potential therapies, and many also lack essential design features and power necessary to provide accurate treatment effect estimates.…”
Get full text
Article -
3357
Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
Published 2017-01-01“…Double-immunofluorescence showed that TfR1, FTH, and FTL were co-expressed to a limited extent with the stem cell-related marker CD133. FTH and FTL were also co-expressed by IBA-1-positive microglia/macrophages. …”
Get full text
Article -
3358
Mendelian Susceptibility to Mycobacterial Diseases (MSMD) in a 13-Year-Old Ethiopian Girl with Autosomal Dominant Interferon Gamma Receptor 1(IFN-γ R1) Defect: A Clinical Diagnosti...
Published 2022-01-01“…Treatments constitute antimycobacterial, interferon-gamma, surgery, and hematopoietic stem cell transplantation (HSCT), which is the only known curative treatment. …”
Get full text
Article -
3359
-
3360
Histopathological and Immunohistochemical Evaluation of Methotrexate-Induced Gonadal Damage in Rats: Role of SCF, mTOR, and SIRT-1
Published 2024-12-01“…In addition, the immunoreactivity intensities of stem cell factor (SCF), mechanistic target of rapamycin (mTOR), and SIRT-1 in both tissues were measured by immunohistochemistry. …”
Get full text
Article